Acuta Capital Partners’s Cellectar Biosciences CLRB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,350	Closed	-$176K	–	43
2024 Q2	$176K	Sell	2,350 -2,433	-51%	-$182K	0.15%	31
2024 Q1	$571K	Sell	4,783 -11,134	-70%	-$1.33M	0.37%	32
2023 Q4	$1.32M	Buy	15,917 +11,874	+294%	+$987K	0.74%	31
2023 Q3	$320K	Buy	+4,043	New	+$320K	0.21%	36